Host defenses to Rickettsia rickettsii infection contribute to increased microvascular permeability in human cerebral endothelial cells

Michael E. Woods, Juan Olano

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Rickettsiae are arthropod-borne intracellular bacterial pathogens that primarily infect the microvascular endothelium leading to systemic spread of the organisms and the major pathophysiological effect, increased microvascular permeability, and edema in vital organs such as the lung and brain. Much work has been done on mechanisms of immunity to rickettsiae, as well as the responses of endothelial cells to rickettsial invasion. However, to date, no one has described the mechanisms of increased microvascular permeability during acute rickettsiosis. We sought to establish an in vitro model of human endothelial-target rickettsial infection using the etiological agent of Rocky Mountain spotted fever, Rickettsia rickettsii, and human cerebral microvascular endothelial cells. Endothelial cells infected with R. rickettsii exhibited a dose-dependent decrease in trans-endothelial electrical resistance, which translates into increased monolayer permeability. Additionally, we showed that the addition of pro-inflammatory stimuli essential to rickettsial immunity dramatically enhanced this effect. This increase in permeability correlates with dissociation of adherens junctions between endothelial cells and is not dependent on the presence of nitric oxide. Taken together, these results demonstrate for the first time that increased microvascular permeability associated with rickettsial infection is partly attributable to intracellular rickettsiae and partly attributable to the immune defenses that have evolved to protect the host from rickettsial spread.

Original languageEnglish (US)
Pages (from-to)174-185
Number of pages12
JournalJournal of Clinical Immunology
Volume28
Issue number2
DOIs
StatePublished - Mar 2008

Fingerprint

Rickettsia Infections
Rickettsia rickettsii
Capillary Permeability
Rickettsia
Endothelial Cells
Immunity
Permeability
Rocky Mountain Spotted Fever
Adherens Junctions
Arthropods
Infection
Electric Impedance
Endothelium
Edema
Nitric Oxide
Lung
Brain

Keywords

  • Bacterial infection
  • Cytokines
  • Microvascular permeability
  • Nitric oxide
  • Rickettsiae

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

@article{2323eced3e7c443a8af7ad44012f0abb,
title = "Host defenses to Rickettsia rickettsii infection contribute to increased microvascular permeability in human cerebral endothelial cells",
abstract = "Rickettsiae are arthropod-borne intracellular bacterial pathogens that primarily infect the microvascular endothelium leading to systemic spread of the organisms and the major pathophysiological effect, increased microvascular permeability, and edema in vital organs such as the lung and brain. Much work has been done on mechanisms of immunity to rickettsiae, as well as the responses of endothelial cells to rickettsial invasion. However, to date, no one has described the mechanisms of increased microvascular permeability during acute rickettsiosis. We sought to establish an in vitro model of human endothelial-target rickettsial infection using the etiological agent of Rocky Mountain spotted fever, Rickettsia rickettsii, and human cerebral microvascular endothelial cells. Endothelial cells infected with R. rickettsii exhibited a dose-dependent decrease in trans-endothelial electrical resistance, which translates into increased monolayer permeability. Additionally, we showed that the addition of pro-inflammatory stimuli essential to rickettsial immunity dramatically enhanced this effect. This increase in permeability correlates with dissociation of adherens junctions between endothelial cells and is not dependent on the presence of nitric oxide. Taken together, these results demonstrate for the first time that increased microvascular permeability associated with rickettsial infection is partly attributable to intracellular rickettsiae and partly attributable to the immune defenses that have evolved to protect the host from rickettsial spread.",
keywords = "Bacterial infection, Cytokines, Microvascular permeability, Nitric oxide, Rickettsiae",
author = "Woods, {Michael E.} and Juan Olano",
year = "2008",
month = "3",
doi = "10.1007/s10875-007-9140-9",
language = "English (US)",
volume = "28",
pages = "174--185",
journal = "Journal of Clinical Immunology",
issn = "0271-9142",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Host defenses to Rickettsia rickettsii infection contribute to increased microvascular permeability in human cerebral endothelial cells

AU - Woods, Michael E.

AU - Olano, Juan

PY - 2008/3

Y1 - 2008/3

N2 - Rickettsiae are arthropod-borne intracellular bacterial pathogens that primarily infect the microvascular endothelium leading to systemic spread of the organisms and the major pathophysiological effect, increased microvascular permeability, and edema in vital organs such as the lung and brain. Much work has been done on mechanisms of immunity to rickettsiae, as well as the responses of endothelial cells to rickettsial invasion. However, to date, no one has described the mechanisms of increased microvascular permeability during acute rickettsiosis. We sought to establish an in vitro model of human endothelial-target rickettsial infection using the etiological agent of Rocky Mountain spotted fever, Rickettsia rickettsii, and human cerebral microvascular endothelial cells. Endothelial cells infected with R. rickettsii exhibited a dose-dependent decrease in trans-endothelial electrical resistance, which translates into increased monolayer permeability. Additionally, we showed that the addition of pro-inflammatory stimuli essential to rickettsial immunity dramatically enhanced this effect. This increase in permeability correlates with dissociation of adherens junctions between endothelial cells and is not dependent on the presence of nitric oxide. Taken together, these results demonstrate for the first time that increased microvascular permeability associated with rickettsial infection is partly attributable to intracellular rickettsiae and partly attributable to the immune defenses that have evolved to protect the host from rickettsial spread.

AB - Rickettsiae are arthropod-borne intracellular bacterial pathogens that primarily infect the microvascular endothelium leading to systemic spread of the organisms and the major pathophysiological effect, increased microvascular permeability, and edema in vital organs such as the lung and brain. Much work has been done on mechanisms of immunity to rickettsiae, as well as the responses of endothelial cells to rickettsial invasion. However, to date, no one has described the mechanisms of increased microvascular permeability during acute rickettsiosis. We sought to establish an in vitro model of human endothelial-target rickettsial infection using the etiological agent of Rocky Mountain spotted fever, Rickettsia rickettsii, and human cerebral microvascular endothelial cells. Endothelial cells infected with R. rickettsii exhibited a dose-dependent decrease in trans-endothelial electrical resistance, which translates into increased monolayer permeability. Additionally, we showed that the addition of pro-inflammatory stimuli essential to rickettsial immunity dramatically enhanced this effect. This increase in permeability correlates with dissociation of adherens junctions between endothelial cells and is not dependent on the presence of nitric oxide. Taken together, these results demonstrate for the first time that increased microvascular permeability associated with rickettsial infection is partly attributable to intracellular rickettsiae and partly attributable to the immune defenses that have evolved to protect the host from rickettsial spread.

KW - Bacterial infection

KW - Cytokines

KW - Microvascular permeability

KW - Nitric oxide

KW - Rickettsiae

UR - http://www.scopus.com/inward/record.url?scp=40149106317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40149106317&partnerID=8YFLogxK

U2 - 10.1007/s10875-007-9140-9

DO - 10.1007/s10875-007-9140-9

M3 - Article

C2 - 17957455

AN - SCOPUS:40149106317

VL - 28

SP - 174

EP - 185

JO - Journal of Clinical Immunology

JF - Journal of Clinical Immunology

SN - 0271-9142

IS - 2

ER -